Product Code: GVR-4-68040-109-5
Platysmaplasty Treatment Market Growth & Trends:
The global platysmaplasty treatment market size is expected to reach USD 1.89 billion by 2030, according to a new report by Grand View Research, Inc.. The market is anticipated to grow at a CAGR of 7.5% from 2023 to 2030. The global market is anticipated to experience substantial growth due to the increasing global demand for aesthetic procedures. As people have become more concerned about their appearance and seek ways to enhance their facial aesthetics, the demand for platysmaplasty, a surgical technique that targets rejuvenating and lifting the neck area, is predicted to rise. In addition, surgical technique advancements and technology are anticipated to drive market growth. Ongoing progress in medical science has led to the development of innovative approaches and tools that enable more effective and improved outcomes in performing platysmaplasty.
As individuals place a greater emphasis on appearance and self-confidence, there is a rising desire to enhance facial aesthetics, including through procedures such as platysmaplasty, which focuses on neck rejuvenation. This growth is exemplified by recent industry data from the International Society of Aesthetic Plastic Surgery, revealing that out of the 6.8 million cosmetic procedures conducted globally, approximately 4.5 million were non-surgical cosmetic procedures performed in the United States alone. This statistic highlights the expanding global market as more people acknowledge the potential benefits of neck rejuvenation procedures and actively seek experienced surgeons and advanced techniques to achieve their desired aesthetic outcomes.
The market was adversely affected by COVID-19 due to reasons such as patients postponing or canceling surgeries due to virus concerns, limited access to healthcare, and resource prioritization. However, the market is anticipated to rebound with improving conditions and higher vaccination rates. The increasing demand for cosmetic procedures, including neck rejuvenation, will likely drive this resurgence. Technological advancements and minimally invasive techniques with shorter recovery periods may also contribute to market growth as patients seek convenient and effective solutions.
Platysmaplasty Treatment Market Report Highlights:
- Based on gender, the female segment held the largest revenue share of 61.1% in 2022. The dominance of the female segment in the market can be attributed to various factors, including societal pressure and the desire to maintain a youthful neck and jawline. Also, adoption and awareness are higher among females
- In terms of end-use, the cosmetic surgery clinics segment held the largest revenue share of 62.0% in 2022 and it is anticipated to witness the highest CAGR of 7.9% during the forecast period. This segment's ascendancy can be attributed to several factors, including the increasing demand for non-invasive and minimally invasive cosmetic procedures, and advancements in technology and techniques
- In terms of region, the North America region dominated the market in 2022 with the largest revenue share of over 35.4%. This is because North America has a highly developed healthcare infrastructure, advanced surgical techniques, and readily available technologies
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information Or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.4.1. Increasing Demand for Aesthetic Procedures
- 3.4.2. Technological Advancements and Surgical Innovations
- 3.4.3. Increasing Demand for Effective Thrombectomy/Embolectomy Devices
- 3.5. Market Restraint Analysis
- 3.5.1. High Cost of Procedures
- 3.5.2. Potential Risks and Complications Associated with Surgeries.
- 3.6. Penetration And Growth Prospect Mapping 2022
- 3.7. Business Environment Analysis
- 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
- 3.7.2. Porter's Five Forces Analysis
- 3.8. COVID-19 Impact Analysis
Chapter 4. Platysmaplasty Treatment Market: Gender Segment Analysis
- 4.1. Platysmaplasty Treatment Market: Market Share Analysis, 2022 & 2030
- 4.2. Male
- 4.2.1. Male Market, 2018 - 2030 (USD Million)
- 4.3. Female
- 4.3.1. Female Market 2018 - 2030 (USD Million)
Chapter 5. Platysmaplasty Treatment Market: End-use Segment Analysis
- 5.1. Platysmaplasty: Market Share Analysis, 2022 & 2030
- 5.2. Cosmetic Surgery Clinics
- 5.2.1. Cosmetic Surgery Clinics Market, 2018 - 2030 (USD Million)
- 5.3. Hospitals
- 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
- 6.1. Platysmaplasty Treatment Market Share By Region, 2022 & 2030
- 6.2. North America
- 6.2.1. North Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. Key Country Dynamics
- 6.2.2.2. Competitive Scenario
- 6.2.2.3. Regulatory Framework
- 6.2.2.4. U.S. Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Key Country Dynamics
- 6.2.3.2. Competitive Scenario
- 6.2.3.3. Regulatory Framework
- 6.2.3.4. Canada Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.2. UK
- 6.3.2.1. Key Country Dynamics
- 6.3.2.2. Competitive Scenario
- 6.3.2.3. Regulatory Framework
- 6.3.2.4. UK Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Key Country Dynamics
- 6.3.3.2. Competitive Scenario
- 6.3.3.3. Regulatory Framework
- 6.3.3.4. Germany Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. Key Country Dynamics
- 6.3.4.2. Competitive Scenario
- 6.3.4.3. Regulatory Framework
- 6.3.4.4. France Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Key Country Dynamics
- 6.3.5.2. Competitive Scenario
- 6.3.5.3. Regulatory Framework
- 6.3.5.4. Italy Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Key Country Dynamics
- 6.3.6.2. Competitive Scenario
- 6.3.6.3. Regulatory Framework
- 6.3.6.4. Spain Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Key Country Dynamics
- 6.3.7.2. Competitive Scenario
- 6.3.7.3. Regulatory Framework
- 6.3.7.4. Denmark Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Key Country Dynamics
- 6.3.8.2. Competitive Scenario
- 6.3.8.3. Regulatory Framework
- 6.3.8.4. Sweden Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Key Country Dynamics
- 6.3.9.2. Competitive Scenario
- 6.3.9.3. Regulatory Framework
- 6.3.9.4. Norway Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.2. Japan
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Competitive Scenario
- 6.4.2.3. Regulatory Framework
- 6.4.2.4. Japan Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.3. China
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Competitive Scenario
- 6.4.3.3. Regulatory Framework
- 6.4.3.4. China Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Competitive Scenario
- 6.4.4.3. Regulatory Framework
- 6.4.4.4. India Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.5. Australia
- 6.4.5.1. Key Country Dynamics
- 6.4.5.2. Competitive Scenario
- 6.4.5.3. Regulatory Framework
- 6.4.5.4. Australia Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.6. Thailand
- 6.4.6.1. Key Country Dynamics
- 6.4.6.2. Competitive Scenario
- 6.4.6.3. Regulatory Framework
- 6.4.6.4. Thailand Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.4.7. South Korea
- 6.4.7.1. Key Country Dynamics
- 6.4.7.2. Competitive Scenario
- 6.4.7.3. Regulatory Framework
- 6.4.7.4. South Korea Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Target Disease Prevalence
- 6.5.2.3. Competitive Scenario
- 6.5.2.4. Regulatory Framework
- 6.5.2.5. Brazil Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.5.3. Mexico
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Competitive Scenario
- 6.5.3.3. Regulatory Framework
- 6.5.3.4. Mexico Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.5.4. Argentina
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Competitive Scenario
- 6.5.4.3. Regulatory Framework
- 6.5.4.4. Argentina Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.6. MEA
- 6.6.1. SWOT Analysis
- 6.6.2. MEA Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.6.3. South Africa
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Competitive Scenario
- 6.6.3.3. Regulatory Framework
- 6.6.3.4. South Africa Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.6.4. Saudi Arabia
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Competitive Scenario
- 6.6.4.3. Regulatory Framework
- 6.6.4.4. Saudi Arabia Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.6.5. UAE
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Competitive Scenario
- 6.6.5.3. Regulatory Framework
- 6.6.5.4. UAE Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
- 6.6.6. Kuwait
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Competitive Scenario
- 6.6.6.3. Regulatory Framework
- 6.6.6.4. Kuwait Platysmaplasty Treatment Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company Categorization
- 7.2. Strategy Mapping
- 7.3. Company Market Share Analysis, 2022
- 7.4. Company Profiles/Listing
- 7.4.1. Long Island Plastic Surgical Group
- 7.4.1.1. Overview
- 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. Dr. Cat Plastic Surgery
- 7.4.2.1. Overview
- 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. Nazarian Plastic Surgery
- 7.4.3.1. Overview
- 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. The Cadogan Clinic
- 7.4.4.1. Overview
- 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Avenue Plastic Surgery
- 7.4.5.1. Overview
- 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. The Istanbul Aesthetic Center
- 7.4.6.1. Overview
- 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. Piedmont Plastic Surgery & Dermatology
- 7.4.7.1. Overview
- 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. Los Angeles Plastic Surgery clinic
- 7.4.8.1. Overview
- 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiatives